Abstract:OBJECTIVE To evaluate the clinical and coronary angiographic features of patients with systemic vasculitis and coronary artery disease. METHOD Fifteen patients (11 male) with systemic vasculitis and coronary artery diseases admitted to our hospital from January 1999 to October 2009 were reviewed. RESULTS There were 6 patients with Behcet's disease, 3 patients with Churg-Strauss syndrome, 2 patients with Takayasu arteritis, 1 patient with polyarteritis nodosa, 1 patient with microscopic polyangiitis, 1 patient with Wegner's granulomatosis and 1 patient with Kawasaki disease. Mean age of this cohort was (39.3 ± 11.9) years. Adverse coronary events occurred in 4 patients during the inactive phase of systemic vasculitis and in 9 patients during the active phase of systemic vasculitis. Twelve patients were hospitalized with acute myocardial infarction, 2 with angina pectoris and 1 with cardiac tamponade. There were 3 patients with acute left ventricular dysfunction and 3 patients with severe arrhythmias. Compared to patients in the inactive phase, patients in the active phase were younger [(32.4 ± 8.1) years vs. (47.0 ± 10.2) years], had less risk factors for atherosclerosis (1.2 ± 1.5 to 2.8 ± 1.7) and the time intervals between coronary artery disease and systemic vasculitis was shorter [0 - 7 years (average 1.6 years) to 3 - 30 years (average 17.7 years)]. Coronary angiography evidenced coronary stenosis or occlusions in 11 patients, coronary aneurysm and acute thrombosis in 1 patient, coronary aneurysms and occlusions in 1 patient and coronary spasm in 2 patients. LVEF measured by echocardiography was less than 50% in 8 patients. CONCLUSION Patients with various systemic vasculitis could develop severe coronary artery disease due to coronary stenosis/occlusion, aneurysma, thrombosis and coronary spasm.

Genetics of vasculitis

Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review

Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing

Unraveling the Immunopathogenesis and Genetic Variants in Vasculitis Toward Development of Personalized Medicine

Pathogenesis and treatment progress of antineutrophil cytoplasmic antibody-associated vasculitis

Global epidemiology of vasculitis

Epidemiology of systemic vasculitis

The genetics of Henoch–Schönlein purpura: a systematic review and meta-analysis

Genetically distinct subsets within ANCA-associated vasculitis

[Clinical and Coronary Angiographic Features of Patients with Systemic Vasculitis and Coronary Artery Disease].

A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren's Syndrome

Identification of Potential Gene Targets in Systemic Vasculitis Using DNA Microarray Analysis.

Pathogenesis of IgA Vasculitis: An Up-To-Date Review

Role of non-coding RNAs and exosomal non-coding RNAs in vasculitis: A narrative review

Cutaneous and systemic vasculitis: cellular players and pathogenetic aspects

Vasculitis and vasculopathy associated with inborn errors of immunity: an overview

IgA Vasculitis Update: Epidemiology, Pathogenesis, and Biomarkers

Telomere dysfunction promotes small vessel vasculitis via the LL37-NETs-dependent mechanism

Vasculitic Neuropathies

Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management

Genetic susceptibility to autoimmune disorders: clues from gene association and gene expression studies